باب
Oxomemazine
رقم CAS
3689-50-7
الصيغة الجزيئية
C₁₈H₂₂N₂O₂S
وزن جزيئي
330.45 g/mol
رقم كاتلوج
MLS-XMM-STD
مرادف

10-(3-(Dimethylamino)-2-methylpropyl)-10H-phenothiazine 5,5-dioxide; 10-[3-(Dimethylamino)-2-methylpropyl]phenothiazine 5,5-Dioxide;3(5,5-Dioxido-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine; (±)-Oxomemazine;

الكلمات الرئيسية
Pharmaceutical Standards
Intermediates
Fine Chemicals
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Oxomemazine Standard (CAS No. 3689-50-7), with molecular formula C₁₈H₂₂N₂O₂S and molecular weight 330.45 g/mol, is offered by Manasa Life Sciences, a trusted manufacturer and supplier in India for pharmaceutical and analytical requirements. Our Oxomemazine Standard supports quality control, analytical testing, impurity profiling, method development, validation, pharmaceutical research, and research and development (R&D). We provide reliable reference standards and analytical support for laboratories, pharmaceutical manufacturers, quality control teams, and research organizations.

Manasa Life Sciences is a trusted of Manufacturer and Supplier in India provides comprehensive analytical characterization and regulatory documentation for Oxomemazine Standard, including HPLC, LC-MS/MS, ¹H NMR, ¹³C NMR, FTIR, GC, QNMR, TGA, potency testing, and Certificate of Analysis (COA). We also offer Structural Elucidation Reports (SER), MSDS/SDS, regulatory submission documents, and customized technical documentation. Our services support impurity identification, pharmaceutical characterization, analytical method development and validation, quality assessment, regulatory documentation, and R&D activities in line with applicable ICH, USP, and EP guidelines.